Biomarkers in Medicine
Leading citation impact metric from Clarivate Journal Citation Reports
37 papers with at least that number of citations each
State Council for Professorship (HĐGSNN) Scoring
Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)
HĐGSNN Score History
By article publication year| Year | Max Score | Evaluation Details | Source |
|---|---|---|---|
| 2026 | 1.50đ | WoS Q3(IF: 2.1) | 🔵 Computed |
| 2025 | 1.50đ | WoS Q3(IF: 2.1) | 🔵 Computed |
| 2024 | 1.50đ | WoS Q3(IF: 1.9) | 🔵 Computed |
| 2023 | 1.50đ | WoS Q3(IF: 2.2) | 🔵 Computed |
| 2022 | 1.50đ | WoS Q3(IF: 2.498) | 🔵 Computed |
| 2021 | 1.50đ | WoS Q3(IF: 2.851) | 🔵 Computed |
| 2020 | 1.50đ | WoS Q3(IF: 2.479) | 🔵 Computed |
| 2019 | 1.50đ | WoS Q3(IF: 2.268) | 🔵 Computed |
| 2018 | 1.50đ | WoS Q3(IF: 2.346) | 🔵 Computed |
Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.
Aims & Scope
Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory. Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice. As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications. Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest. Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Measures cumulative publication volume and citation impact.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
| Category | Index | Rank | Quartile |
|---|---|---|---|
MEDICINE, RESEARCH & EXPERIMENTAL | JCRSCIE | 121/191 | Q3 |
MEDICINE, RESEARCH & EXPERIMENTAL | JCISCIE | 112/191 | Q3 |
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
| Year | Impact Factor | Articles / Year | Total Citations |
|---|---|---|---|
| 2026 | — | 75 | 22 |
| 2025 | 2.1 | 143 | 228 |
| 2024 | 1.9 | 115 | 468 |
| 2023 | 2.2 | 94 | 539 |
| 2022 | 2.498 | 133 | 971 |
| 2021 | 2.851 | 170 | 1,523 |
| 2020 | 2.479 | 157 | 2,204 |
| 2019 | 2.268 | 154 | 2,471 |
| 2018 | 2.346 | 128 | 2,530 |
| 2017 | — | 130 | 2,749 |
| 2016 | — | 122 | 2,758 |
| 2015 | — | 140 | 2,750 |
Journal Metrics & Citation Visualizations
Impact Factor Trend (2018–2024)
Clarivate IF trend for Biomarkers in Medicine
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics